1. Home
  2. AZN
  3. AZN News

Latest AstraZeneca PLC (AZN) News on March 29, 2025

U.S. to end funding for child vaccines in developing countries, NY Times reports
AZN

TipRanks

2 days ago

U.S. to end funding for child vaccines in developing countries, NY Times reports

Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a Bet
AZN

Zacks

2 days ago

Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a Bet

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology
AZN

Pharma Voice

2 days ago

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

AstraZeneca says new results reinforce Tagrisso as backbone therapy
AZN

TipRanks

3 days ago

AstraZeneca says new results reinforce Tagrisso as backbone therapy

Astrazeneca (AZN) Stock Moves -0.45%: What You Should Know
AZN

Zacks

3 days ago

Astrazeneca (AZN) Stock Moves -0.45%: What You Should Know

New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings
AZN

Business Wire

4 days ago

New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings

Assemblin to upgrade AstraZeneca’s Gärtuna plant in Sweden
AZN

World Construction Network

5 days ago

Assemblin to upgrade AstraZeneca’s Gärtuna plant in Sweden

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
AZN

Zacks

5 days ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

AstraZeneca to invest $2.5bn in R&D centre in China
AZN

Pharmaceutical Technology

5 days ago

AstraZeneca to invest $2.5bn in R&D centre in China

Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead
AZN

Motley Fool

6 days ago

Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead

AZN

MT Newswires

8 days ago

Sector Update: Health Care Stocks Retreat Late Afternoon

AZN

MT Newswires

8 days ago

Sector Update: Health Care Stocks Fall in Afternoon Trading

AZN

MT Newswires

8 days ago

Sector Update: Health Care

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals
AZN

Zacks

8 days ago

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals

Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue?
AZN

Zacks

8 days ago

Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue?

AstraZeneca to invest £2bn in Beijing amid China investigation
AZN

The Telegraph

8 days ago

AstraZeneca to invest £2bn in Beijing amid China investigation

Micron, Johnson & Johnson, AstraZeneca: Top Stocks
AZN

Yahoo Finance Video

8 days ago

Micron, Johnson & Johnson, AstraZeneca: Top Stocks

AstraZeneca to Invest $2.5 Billion in China Amid Probes
AZN

The Wall Street Journal

8 days ago

AstraZeneca to Invest $2.5 Billion in China Amid Probes

AstraZeneca Invests $2.5 Billion in R&D Center in China
AZN

The Wall Street Journal

8 days ago

AstraZeneca Invests $2.5 Billion in R&D Center in China

AstraZeneca Invests $2.5 Billion in Beijing Hub Amid Probe
AZN

Bloomberg

8 days ago

AstraZeneca Invests $2.5 Billion in Beijing Hub Amid Probe

AZN

MT Newswires

8 days ago

Update: Market Chatter: AstraZeneca to Invest $2.5 Billion in Beijing Despite Recent Detaining of Executive

AZN

MT Newswires

8 days ago

Market Chatter: AstraZeneca to Invest $2.5 Billion in Beijing Despite Recent Detaining of Executive

AZN

Financial Times

8 days ago

AstraZeneca to invest $2.5bn in China after scandal

AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals
AZN

Reuters

8 days ago

AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals

Here’s Why Parnassus Growth Equity Fund Decided to Sell AstraZeneca PLC (AZN)
AZN

Insider Monkey

9 days ago

Here’s Why Parnassus Growth Equity Fund Decided to Sell AstraZeneca PLC (AZN)

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
AZN

Zacks

10 days ago

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know

Is AstraZeneca (AZN) the Best European Stock to Buy According to Billionaires?
AZN

Insider Monkey

11 days ago

Is AstraZeneca (AZN) the Best European Stock to Buy According to Billionaires?

AstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase III
AZN

Clinical Trials Arena

11 days ago

AstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase III

AstraZeneca and Alteogen agree on ALT-B4 platform tech
AZN

Pharmaceutical Technology

11 days ago

AstraZeneca and Alteogen agree on ALT-B4 platform tech

AZN

MT Newswires

12 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

AZN

MT Newswires

12 days ago

Sector Update: Health Care Stocks Gain Monday Afternoon

AZN

MT Newswires

12 days ago

Sector Update: Health Care

AZN

MT Newswires

12 days ago

European Equities Rise in Monday Trading; AstraZeneca to Acquire EsoBiotec for Up to $1 Billion

AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer
AZN

Zacks

12 days ago

AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer

AZN

MT Newswires

12 days ago

AstraZeneca's Imfinzi Approved by EU for Treatment of Small Cell Lung Cancer

IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals
AZN

PR Newswire

12 days ago

IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals

Eventful Monday For AstraZeneca - What's Going On?
AZN

Benzinga

12 days ago

Eventful Monday For AstraZeneca - What's Going On?

AstraZeneca Strikes up to $1 Billion Deal to Buy EsoBiotec
AZN

MT Newswires

12 days ago

AstraZeneca Strikes up to $1 Billion Deal to Buy EsoBiotec

AZN

MT Newswires

12 days ago

AstraZeneca Enters Deal to Acquire Cell Therapy Firm EsoBiotec for Up to $1 Billion

AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost Cell-Therapy Portfolio
AZN

The Wall Street Journal

12 days ago

AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost Cell-Therapy Portfolio

AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy
AZN

Reuters

12 days ago

AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy

EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition
AZN

GlobeNewswire

12 days ago

EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition

AstraZeneca Stock Scores RS Rating Upgrade
AZN

Investor's Business Daily

15 days ago

AstraZeneca Stock Scores RS Rating Upgrade

AZN

Morningstar Research

15 days ago

Analyst Report: AstraZeneca PLC

INOVIO’s Covid-19 dMAb maintains in-vivo detection in 100% participants
AZN

Clinical Trials Arena

15 days ago

INOVIO’s Covid-19 dMAb maintains in-vivo detection in 100% participants

AstraZeneca director says AI must be a “thought partner” in drug discovery
AZN

Pharmaceutical Technology

15 days ago

AstraZeneca director says AI must be a “thought partner” in drug discovery

AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer
AZN

Business Wire

15 days ago

AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer

AstraZeneca Stock Nears Buy Point After Long Run In Declining Market
AZN

Investor's Business Daily

16 days ago

AstraZeneca Stock Nears Buy Point After Long Run In Declining Market

Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?
AZN

Zacks

16 days ago

Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?

Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know
AZN

Zacks

17 days ago

Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know

Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion
AZN

Investor's Business Daily

17 days ago

Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion

AZN

Argus Research

17 days ago

Analyst Report: AstraZeneca PLC

AZN

Argus Research

17 days ago

Market Update: CME, LHX, NYT, SHW, SJM, AZN

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe
AZN

Zacks

18 days ago

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe

AstraZeneca and Ionis win EU approval for ATTR polyneuropathy
AZN

Pharmaceutical Technology

19 days ago

AstraZeneca and Ionis win EU approval for ATTR polyneuropathy

AZN

MT Newswires

19 days ago

Ionis Pharmaceuticals Says Transthyretin-Mediated Amyloidosis Treatment Gets Approval in Europe

AstraZeneca reports positive outcomes from trial of Imfinzi
AZN

Clinical Trials Arena

19 days ago

AstraZeneca reports positive outcomes from trial of Imfinzi

AZN

MT Newswires

22 days ago

Astrazeneca Adjunctive Gastric Cancer Treatment Study Meets Primary Endpoint

AstraZeneca's Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients
AZN

Benzinga

22 days ago

AstraZeneca's Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients

IMFINZI® (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction cancers
AZN

Business Wire

22 days ago

IMFINZI® (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction cancers

Astrazeneca (AZN) Stock Moves -0.63%: What You Should Know
AZN

Zacks

23 days ago

Astrazeneca (AZN) Stock Moves -0.63%: What You Should Know

Is AstraZeneca PLC (LON:AZN) Trading At A 45% Discount?
AZN

Simply Wall St.

23 days ago

Is AstraZeneca PLC (LON:AZN) Trading At A 45% Discount?

What Trump's next batch of tariffs could mean for pharma industry
AZN

Yahoo Finance Video

24 days ago

What Trump's next batch of tariffs could mean for pharma industry

Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
AZN

GuruFocus.com

24 days ago

Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

EU set to approve AstraZeneca’s Imfinzi-chemo combo for NSCLC
AZN

Pharmaceutical Technology

25 days ago

EU set to approve AstraZeneca’s Imfinzi-chemo combo for NSCLC

Daiichi Sankyo and AstraZeneca’s Enhertu shows OS improvements in Phase III trial
AZN

Clinical Trials Arena

25 days ago

Daiichi Sankyo and AstraZeneca’s Enhertu shows OS improvements in Phase III trial

Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP
AZN

Clinical Trials Arena

a month ago

Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP

AZN

MT Newswires

a month ago

Astrazeneca-Amgen Asthma Treatment Reduces Nasal Polyps, Surgery Rates in Phase III Trial

Is AstraZeneca PLC (AZN) The Best Immunology Stock To Buy Now?
AZN

Insider Monkey

a month ago

Is AstraZeneca PLC (AZN) The Best Immunology Stock To Buy Now?

Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps
AZN

Business Wire

a month ago

Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps

Is AstraZeneca PLC (AZN) the Best Weight Loss Drug Stock to Buy According to Analysts?
AZN

Insider Monkey

a month ago

Is AstraZeneca PLC (AZN) the Best Weight Loss Drug Stock to Buy According to Analysts?

Here's Why Astrazeneca (AZN) Gained But Lagged the Market Today
AZN

Zacks

a month ago

Here's Why Astrazeneca (AZN) Gained But Lagged the Market Today

Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More
AZN

Zacks

a month ago

Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More

AZN

MT Newswires

a month ago

Astrazeneca's Breast Cancer Drug Recommended for Approval in EU

Drug Stocks Are the New Safe Bet in a Shaky Market
AZN

The Wall Street Journal

a month ago

Drug Stocks Are the New Safe Bet in a Shaky Market

AstraZeneca reports positive outcomes from breast cancer combo therapy trial
AZN

Clinical Trials Arena

a month ago

AstraZeneca reports positive outcomes from breast cancer combo therapy trial

AstraZeneca PLC (AZN): One of the Best Vaccine Stocks to Buy According to Hedge Funds
AZN

Insider Monkey

a month ago

AstraZeneca PLC (AZN): One of the Best Vaccine Stocks to Buy According to Hedge Funds

AZN

MT Newswires

a month ago

Astrazeneca Says Interim Data From Breast Cancer Therapy Study Shows Promise

AZN

Investing.com

a month ago

AstraZeneca breast cancer drug shows positive results, shares up

Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial
AZN

Business Wire

a month ago

Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial

AstraZeneca’s next breast cancer drug; Madrigal’s accelerating MASH launch
AZN

BioPharma Dive

a month ago

AstraZeneca’s next breast cancer drug; Madrigal’s accelerating MASH launch

AstraZeneca PLC (AZN): A High Growth Mega Cap Stock You Can Buy and Hold for the Next 5 Years
AZN

Insider Monkey

a month ago

AstraZeneca PLC (AZN): A High Growth Mega Cap Stock You Can Buy and Hold for the Next 5 Years

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
AZN

PR Newswire

a month ago

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

AstraZeneca PLC (AZN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
AZN

Insider Monkey

a month ago

AstraZeneca PLC (AZN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

3 Magnificent Growth Stocks to Buy Right Now
AZN

Motley Fool

a month ago

3 Magnificent Growth Stocks to Buy Right Now

AstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge Funds
AZN

Insider Monkey

a month ago

AstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge Funds

FibroGen sells China unit to AstraZeneca for $160m
AZN

Pharmaceutical Technology

a month ago

FibroGen sells China unit to AstraZeneca for $160m

AstraZeneca Rises Almost 9% in a Month: How to Play the Stock
AZN

Zacks

a month ago

AstraZeneca Rises Almost 9% in a Month: How to Play the Stock

Ionis' Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus
AZN

Zacks

a month ago

Ionis' Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus

AZN

MT Newswires

a month ago

FibroGen to Sell China Unit to AstraZeneca for $160 Million

Here’s Why AstraZeneca PLC (AZN) Traded Lower in Q4
AZN

Insider Monkey

a month ago

Here’s Why AstraZeneca PLC (AZN) Traded Lower in Q4

AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal
AZN

Reuters

a month ago

AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal

AstraZeneca deepens China presence with FibroGen deal
AZN

BioPharma Dive

a month ago

AstraZeneca deepens China presence with FibroGen deal

AZN

Thomson Reuters StreetEvents

a month ago

Q4 2024 Ionis Pharmaceuticals Inc Earnings Call

AstraZeneca Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
AZN

Simply Wall St.

a month ago

AstraZeneca Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

AstraZeneca (LON:AZN) Is Posting Promising Earnings But The Good News Doesn’t Stop There
AZN

Simply Wall St.

a month ago

AstraZeneca (LON:AZN) Is Posting Promising Earnings But The Good News Doesn’t Stop There

AstraZeneca’s Imfinzi bladder cancer regimen improves survival in Phase III trial
AZN

Clinical Trials Arena

a month ago

AstraZeneca’s Imfinzi bladder cancer regimen improves survival in Phase III trial

AstraZeneca: IMFINZI improved event-free survival, OS across MIBC
AZN

TipRanks

a month ago

AstraZeneca: IMFINZI improved event-free survival, OS across MIBC

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
AZN

Motley Fool

a month ago

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

AZN

MT Newswires

a month ago

AstraZeneca's Bladder Cancer Treatment Improves Survival in Phase 3 Trial

Share on Social Networks: